Lloyd Damon, MD
Professor
Medicine
School of Medicine
Dr. Lloyd Damon is a hematologist and researcher who specializes in blood cancers such as lymphomas and leukemias.
Show full bio (160 words) Hide full bio
Damon studies new treatments for acute myeloid and acute lymphoblastic leukemias. In 1995, he was an early investigator of rituximab, the first monoclonal antibody approved to treat human cancer, specifically lymphoma. (Monoclonal antibodies are cancer-fighting molecules produced in the lab and then infused to work with the patient's immune system against cancer.) In 1998, Damon developed a high-dose regimen for mantle cell lymphoma involving autologous stem cell transplants – which use the patient's own stem cells. When studying cytarabine, an important leukemia drug, he discovered the risk factors for an uncommon toxic effect it can have on the brain and then developed a method for modifying the dose that reduces this side effect significantly.
Damon earned his medical degree at the University of Michigan. He completed an internal medicine residency and a fellowship in hematology and oncology at UCSF, where he joined the faculty in 1988. He is deputy chief of the Divisions of Hematology and Medical Oncology.
Education & Training
Show all (2) Hide
- Post-Doc Fellow/Scholar Medicine (Cancer Research Institute) University of California, San Francisco 1987
- Residency School of Medicine University of California, San Francisco
Websites
Show all (2) Hide
- Profile at UCSF Cancer Center (cancer.ucsf.edu)
- Clinical Profile at UCSF Medical Center (ucsfhealth.org)
Publications (112)
Top publication keywords:
Peripheral Blood Stem Cell TransplantationLeukemia, Myeloid, AcuteHematopoietic Stem Cell MobilizationHematopoietic Stem Cell TransplantationAntibodies, Monoclonal, Murine-DerivedTransplantation, AutologousGranulocyte Colony-Stimulating FactorPrecursor Cell Lymphoblastic Leukemia-LymphomaEtoposideAntimetabolites, AntineoplasticLymphoma, Non-HodgkinLymphoma, Mantle-CellCytarabineAntineoplastic Combined Chemotherapy ProtocolsTransplantation Conditioning
-
Association of geriatric measures and global frailty with cognitive decline after allogeneic hematopoietic cell transplantation in older adults.
Journal of geriatric oncology 2023 Huang LW, Shi Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Boscardin WJ, Steinman MA, Olin RL -
Evaluation of venous thromboembolism prophylaxis protocol in hematopoietic cell transplant patients.
Bone marrow transplantation 2023 Lee A, Badgley C, Lo M, Banez MT, Graff L, Damon L, Martin T, Dzundza J, Wong M, Olin R -
Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
Transplantation and cellular therapy 2022 Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Huang CY, Olin RL -
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
The Lancet. Oncology 2021 Schuster SJ, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Bishop MR, Damon LE, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu JM, Izutsu K, … -
Inhibition of MET Signaling with Ficlatuzumab in Combination with Chemotherapy in Refractory AML: Clinical Outcomes and High-Dimensional Analysis.
Blood cancer discovery 2021 Wang VE, Blaser BW, Patel RK, Behbehani GK, Rao AA, Durbin-Johnson B, Jiang T, Logan AC, Settles M, Mannis GN, Olin R, Damon LE, Martin TG, Sayre PH, Gaensler KM, McMahon E, Flanders M, Weinberg V, Ye…
Show all (107 more) Hide
-
Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis.
Infection control and hospital epidemiology 2021 Trinh TD, Strnad L, Damon L, Dzundza JH, Graff LR, Griffith LM, Hilts-Horeczko A, Olin R, Shenoy S, DeVoe C, Wang L, Rodriguez-Monguio R, Gu TM, Hampton SR, Macapinlac BAC, Yang K, Doernberg SB -
Efficacy of Venetoclax and Dexamethasone in Refractory IgM Primary Plasma Cell Leukemia with t(11;14) and TP53 Mutation: A Case Report and Literature Review.
Case reports in hematology 2020 Valliani S, Ali M, Mahmoo O, Hinduja S, Chen CK, Damon L, Abdulhaq H -
Ofatumumab, Etoposide, and Cytarabine Intensive Mobilization Regimen in Patients with High-risk Relapsed/Refractory Diffuse Large B-Cell Lymphoma Undergoing Autologous Stem Cell Transplantation.
Clinical lymphoma, myeloma & leukemia 2020 Kambhampati S, Hunter B, Varnavski A, Fakhri B, Kaplan L, Ai WZ, Pampaloni M, Huang CY, Martin T, Damon L, Andreadis CB -
Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
Journal of geriatric oncology 2020 Nawas MT, Sheng Y, Huang CY, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Olin RL -
Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.
Molecular therapy : the journal of the American Society of Gene Therapy 2020 Ko AH, Jordan AC, Tooker E, Lacey SF, Chang RB, Li Y, Venook AP, Tempero M, Damon L, Fong L, O'Hara MH, Levine BL, Melenhorst JJ, Plesa G, June CH, Beatty GL -
Rapid Improvement in Gemcitabine-associated Thrombotic Microangiopathy After a Single Dose of Eculizumab: Case Report and Review of the Literature.
Anticancer research 2020 Burns ST, Damon L, Akagi N, Laszik Z, Ko AH -
Impact of Plerixafor Use at Different Peripheral Blood CD34+ Thresholds on Autologous Stem Cell Collection in Patients with Multiple Myeloma.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Shah EE, Young RP, Wong SW, Damon LE, Wolf JL, Shah ND, Leavitt AD, Loeffler P, Martin TG -
Progressive Neurological Impairment and an Enhancing Brainstem Lesion in a Middle-aged Man.
JAMA neurology 2019 Gupta S, Damon L, Gelfand JM -
Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Huang LW, Sheng Y, Andreadis C, Logan AC, Mannis GN, Smith CC, Gaensler KML, Martin TG, Damon LE, Steinman MA, Huang CY, Olin RL -
Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2019 Wieduwilt MJ, Pawlowska N, Thomas S, Olin R, Logan AC, Damon LE, Martin T, Kang M, Sayre PH, Boyer W, Gaensler KML, Anderson K, Munster PN, Andreadis C -
Three prophylaxis regimens (tacrolimus, mycophenolate mofetil, and cyclophosphamide; tacrolimus, methotrexate, and bortezomib; or tacrolimus, methotrexate, and maraviroc) versus tacrolimus and methotrexate for prevention of graft-versus-host disease with haemopoietic cell transplantation with reduced-intensity conditioning: a randomised phase 2 trial with a non-randomised contemporaneous control group (BMT CTN 1203).
The Lancet. Haematology 2019 Bolaños-Meade J, Reshef R, Fraser R, Fei M, Abhyankar S, Al-Kadhimi Z, Alousi AM, Antin JH, Arai S, Bickett K, Chen YB, Damon LE, Efebera YA, Geller NL, Giralt SA, Hari P, Holtan SG, Horowitz MM, … -
Limitation in Patient-Reported Function Is Associated with Inferior Survival in Older Adults Undergoing Autologous Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2019 Nawas MT, Andreadis C, Martin TG, Wolf JL, Ai WZ, Kaplan LD, Mannis GN, Logan AC, Damon LE, Huang CY, Olin RL -
The Use of Natural Health Products Especially Papaya Leaf Extract and Dandelion Root Extract in Previously Untreated Chronic Myelomonocytic Leukemia.
Case reports in hematology 2018 Rahmat LT, Damon LE -
High-Dose Vincristine Sulfate Liposome Injection, for Advanced, Relapsed, or Refractory Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in an Adolescent and Young Adult Subgroup of a Phase 2 Clinical Trial.
Journal of adolescent and young adult oncology 2018 Schiller GJ, Damon LE, Coutre SE, Hsu P, Bhat G, Douer D -
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.
Journal of the National Comprehensive Cancer Network : JNCCN 2017 Brown PA, Shah B, Fathi A, Wieduwilt M, Advani A, Aoun P, Barta SK, Boyer MW, Bryan T, Burke PW, Cassaday R, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Frankfurt O, Greer JP, Kantarjian HM, Klisovic… -
Multigene Measurable Residual Disease Assessment Improves Acute Myeloid Leukemia Relapse Risk Stratification in Autologous Hematopoietic Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016 Mulé MP, Mannis GN, Wood BL, Radich JP, Hwang J, Ramos NR, Andreadis C, Damon L, Logan AC, Martin TG, Hourigan CS -
The use of ibrutinib in chronic lymphocytic leukemia.
Clinical advances in hematology & oncology : H&O 2016 Damon LE -
Quantification of Acute Lymphoblastic Leukemia Clonotypes in Leukapheresed Peripheral Blood Progenitor Cells Predicts Relapse Risk after Autologous Hematopoietic Stem Cell Transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2016 Mannis GN, Martin TG, Damon LE, Andreadis C, Olin RL, Kong KA, Faham M, Hwang J, Ai WZ, Gaensler KML, Sayre PH, Wolf JL, Logan AC -
Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.
Leukemia & lymphoma 2016 Mannis GN, Martin TG, Damon LE, Logan AC, Olin RL, Flanders MD, Ai WZ, Gaensler KM, Kaplan LD, Sayre PH, Smith CC, Wolf JL, Andreadis C -
Acute Lymphoblastic Leukemia, Version 2.2015.
Journal of the National Comprehensive Cancer Network : JNCCN 2015 Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U, Boyer MW, Burke PW, Cassaday R, Castro JE, Coccia PF, Coutre SE, Damon LE, DeAngelo DJ, Douer D, Frankfurt O, Greer JP, Johnson RA, … -
Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study.
The Lancet. Oncology 2015 Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange… -
KIR and HLA genotypes predictive of low-affinity interactions are associated with lower relapse in autologous hematopoietic cell transplantation for acute myeloid leukemia.
Journal of immunology (Baltimore, Md. : 1950) 2015 Marra J, Greene J, Hwang J, Du J, Damon L, Martin T, Venstrom JM -
Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2015 Stone RM, Mazzola E, Neuberg D, Allen SL, Pigneux A, Stuart RK, Wetzler M, Rizzieri D, Erba HP, Damon L, Jang JH, Tallman MS, Warzocha K, Masszi T, Sekeres MA, Egyed M, Horst HA, Selleslag D, Solomon … -
A phase I study of targeted, dose-escalated intravenous busulfan in combination with etoposide as myeloablative therapy for autologous stem cell transplantation in acute myeloid leukemia.
Clinical lymphoma, myeloma & leukemia 2015 Mannis GN, Andreadis C, Logan AC, Damon LE, Benet LZ, Ai WZ, Gaensler KM, Kaplan LD, Koplowicz YB, Linker CA, Olin RL, Sayre PH, Smith CC, Sudhindra A, Venstrom JM, Wolf JL, Martin TG -
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Blood 2014 Lindsley RC, Mar BG, Mazzola E, Grauman PV, Shareef S, Allen SL, Pigneux A, Wetzler M, Stuart RK, Erba HP, Damon LE, Powell BL, Lindeman N, Steensma DP, Wadleigh M, DeAngelo DJ, Neuberg D, Stone RM, … -
Delayed hematopoietic recovery after auto-SCT in patients receiving arsenic trioxide-based therapy for acute promyelocytic leukemia: a multi-center analysis.
Bone marrow transplantation 2014 Mannis GN, Logan AC, Leavitt AD, Yanada M, Hwang J, Olin RL, Damon LE, Andreadis C, Ai WZ, Gaensler KM, Greene CC, Gupta NK, Kaplan LD, Mahindra A, Miyazaki Y, Naoe T, Ohtake S, Sayre PH, Smith CC, … -
Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Journal of geriatric oncology 2014 Keller JW, Andreadis C, Damon LE, Kaplan LD, Martin TG, Wolf JL, Ai WZ, Venstrom JM, Smith CC, Gaensler KM, Hwang J, Olin RL -
Phase 2 trial of CPX-351, a fixed 5:1 molar ratio of cytarabine/daunorubicin, vs cytarabine/daunorubicin in older adults with untreated AML.
Blood 2014 Lancet JE, Cortes JE, Hogge DE, Tallman MS, Kovacsovics TJ, Damon LE, Komrokji R, Solomon SR, Kolitz JE, Cooper M, Yeager AM, Louie AC, Feldman EJ -
Acute myeloid leukemia, version 2.2013.
Journal of the National Comprehensive Cancer Network : JNCCN 2013 O'Donnell MR, Tallman MS, Abboud CN, Altman JK, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Lancet J, Maness LJ, Marcucci G, Martin MG, Millenson MM, Moore JO, Ravandi F, Shami PJ,… -
A 75-year-old woman with thoracic spinal cord compression and chloroma (granulocytic sarcoma).
Seminars in oncology 2012 Baikaidi M, Chung SS, Tallman MS, Damon LE, Walker AR, Marcucci G, Sholi AM, Morris GJ -
Multicenter phase 1 trial of intraventricular immunochemotherapy in recurrent CNS lymphoma.
Blood 2012 Rubenstein JL, Li J, Chen L, Advani R, Drappatz J, Gerstner E, Batchelor T, Krouwer H, Hwang J, Auerback G, Kadoch C, Lowell C, Munster P, Cha S, Shuman MA, Damon LE -
High-dose vincristine sulfate liposome injection for advanced, relapsed, and refractory adult Philadelphia chromosome-negative acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2012 O'Brien S, Schiller G, Lister J, Damon L, Goldberg S, Aulitzky W, Ben-Yehuda D, Stock W, Coutre S, Douer D, Heffner LT, Larson M, Seiter K, Smith S, Assouline S, Kuriakose P, Maness L, Nagler A, Rowe … -
A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine.
Leukemia & lymphoma 2012 Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J -
NCCN Clinical Practice Guidelines Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2012 O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Arber DA, Attar E, Borate U, Coutre SE, Damon LE, Goorha S, Lancet J, Maness LJ, Marcucci G, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, … -
Acute lymphoblastic leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2012 Alvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, DeAngelo DJ, Douer D, Frangoul H, Frankfurt O, Goorha S, Millenson MM, O'… -
Proteinuria in metastatic pheochromocytoma is associated with an increased risk of Acute Respiratory Distress Syndrome, spontaneously or after therapy with 131I-meta-iodobenzylguanidine (131I-MIBG).
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme 2012 Porzig A, Matthay KK, Dubois S, Pampaloni M, Damon L, Hawkins R, Goldsby R, Hollinger F, Fitzgerald P -
20q- clonality in a case of oral sweet syndrome and myelodysplasia.
American journal of clinical pathology 2012 Van Loon K, Gill RM, McMahon P, Chigurupati R, Siddiqi I, Fox L, Damon L, McCalmont TH, Jordan R, Wolf J -
Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012 Wieduwilt MJ, Valles F, Issa S, Behler CM, Hwang J, McDermott M, Treseler P, O'Brien J, Shuman MA, Cha S, Damon LE, Rubenstein JL -
Detection of minimal residual disease following induction immunochemotherapy predicts progression free survival in mantle cell lymphoma: final results of CALGB 59909.
Haematologica 2011 Liu H, Johnson JL, Koval G, Malnassy G, Sher D, Damon LE, Hsi ED, Bucci DM, Linker CA, Cheson BD, Stock W -
Experience with use of Zostavax(®) in patients with hematologic malignancy and hematopoietic cell transplant recipients.
American journal of hematology 2011 Naidus E, Damon L, Schwartz BS, Breed C, Liu C -
Prevention and management of asparaginase/pegasparaginase-associated toxicities in adults and older adolescents: recommendations of an expert panel.
Leukemia & lymphoma 2011 Stock W, Douer D, DeAngelo DJ, Arellano M, Advani A, Damon L, Kovacsovics T, Litzow M, Rytting M, Borthakur G, Bleyer A -
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2011 O'Donnell MR, Abboud CN, Altman J, Appelbaum FR, Coutre SE, Damon LE, Foran JM, Goorha S, Maness LJ, Marcucci G, Maslak P, Millenson MM, Moore JO, Ravandi F, Shami PJ, Smith BD, Stone RM, Strickland … -
Pandemic (H1N1) 2009 infection in patients with hematologic malignancy.
Emerging infectious diseases 2010 Liu C, Schwartz BS, Vallabhaneni S, Nixon M, Chin-Hong PV, Miller SA, Chiu C, Damon L, Drew WL -
Autologous hematopoietic cell transplantation for high-risk ALL.
Bone marrow transplantation 2010 Linker C, Damon L, Martin T, Blume K, Forman S, Snyder D, Wolf J, Negrin R -
Graft-versus-host disease presenting with pancytopenia after en bloc multiorgan transplantation: case report and literature review.
Transplantation proceedings 2009 Mawad R, Hsieh A, Damon L -
Mobilization of hematopoietic stem cells into the peripheral blood.
Expert review of hematology 2009 Damon LE, Damon LE -
Immunochemotherapy and autologous stem-cell transplantation for untreated patients with mantle-cell lymphoma: CALGB 59909.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Damon LE, Johnson JL, Niedzwiecki D, Cheson BD, Hurd DD, Bartlett NL, Lacasce AS, Blum KA, Byrd JC, Kelly M, Stock W, Linker CA, Canellos GP -
Voriconazole is safe and effective as prophylaxis for early and late fungal infections following allogeneic hematopoietic stem cell transplantation.
Transplant infectious disease : an official journal of the Transplantation Society 2009 Martin T, Sharma M, Damon L, Kaplan L, Guglielmo BJ, Working M, O'Malley R, Hwang J, Linker C -
Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009 Gonias S, Goldsby R, Matthay KK, Hawkins R, Price D, Huberty J, Damon L, Linker C, Sznewajs A, Shiboski S, Fitzgerald P -
Rituximab therapy for pure red cell aplasia due to anti-epoetin antibodies in a woman treated with epoetin-alfa: a case report.
Journal of medical case reports 2009 Behler CM, Terrault NA, Etzell JE, Damon LE -
Granulocyte-macrophage colony-stimulating factor (GM-CSF)-secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML).
Blood 2009 Borrello IM, Levitsky HI, Stock W, Sher D, Qin L, DeAngelo DJ, Alyea EP, Stone RM, Damon LE, Linker CA, Maslyar DJ, Hege KM -
Auto-SCT for AML in second remission: CALGB study 9620.
Bone marrow transplantation 2009 Linker CA, Owzar K, Powell B, Hurd D, Damon LE, Archer LE, Larson RA, Cancer and Leukemia Group B -
Acute myeloid leukemia.
Journal of the National Comprehensive Cancer Network : JNCCN 2008 O'Donnell MR, Appelbaum FR, Coutre SE, Damon LE, Erba HP, Foran J, Lancet J, Maness LJ, Marcucci G, Maslak PG, Millenson M, Moore JO, Ravandi F, Schuening F, Shami P, Smith BD, Stone RM, Tallman MS, … -
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study.
Leukemia & lymphoma 2008 Hsi ED, Jung SH, Lai R, Johnson JL, Cook JR, Jones D, Devos S, Cheson BD, Damon LE, Said J -
Impact of intensive PBSC mobilization therapy on outcomes following auto-SCT for non-Hodgkin's lymphoma.
Bone marrow transplantation 2008 Damon L, Damon LE, Gaensler K, Kaplan L, Martin T, Rubenstein J, Linker C -
Non-Hodgkin's lymphomas.
Journal of the National Comprehensive Cancer Network : JNCCN 2008 Zelenetz AD, Advani RH, Byrd JC, Czuczman MS, Damon LE, Duvic M, Fayad L, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Horwitz SM, Kaminski MS, Kim YH, Lacasce AS, Nademanee A, … -
Protein biomarker identification in the CSF of patients with CNS lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Roy S, Josephson SA, Fridlyand J, Karch J, Kadoch C, Karrim J, Damon L, Treseler P, Kunwar S, Shuman MA, Jones T, Becker CH, Schulman H, Rubenstein JL -
Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007 Rubenstein JL, Fridlyand J, Abrey L, Shen A, Karch J, Wang E, Issa S, Damon L, Prados M, McDermott M, O'Brien J, Haqq C, Shuman M -
Amyloidosis localized to the liver.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2007 Fix OK, Damon LE, Bass NM -
A randomized, controlled Phase III trial of therapeutic plasma exchange with fresh-frozen plasma (FFP) prepared with amotosalen and ultraviolet A light compared to untreated FFP in thrombotic thrombocytopenic purpura.
Transfusion 2006 Mintz PD, Neff A, MacKenzie M, Goodnough LT, Hillyer C, Kessler C, McCrae K, Menitove JE, Skikne BS, Damon L, Lopez-Plaza I, Rouault C, Crookston KP, Benjamin RJ, George J, Lin JS, Corash L, Conlan MG -
Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG).
Annals of the New York Academy of Sciences 2006 Fitzgerald PA, Goldsby RE, Huberty JP, Price DC, Hawkins RA, Veatch JJ, Dela Cruz F, Jahan TM, Linker CA, Damon L, Matthay KK -
Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006 Damon L, Rugo H, Tolaney S, Navarro W, Martin T, Ries C, Case D, Ault K, Linker C -
Non-Hodgkin's lymphoma. Clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006 Zelenetz AD, Advani RH, Buadi F, Cabanillas F, Caligiuri MA, Czuczman MS, Damon LE, Fayad L, Flinn IW, Forero A, Glenn MJ, Gockerman JP, Gordon LI, Harris NL, Hoppe RT, Kaminski MS, Lacasce AS, … -
Acute myeloid leukemia clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006 O'Donnell MR, Appelbaum FR, Baer MR, Byrd JC, Coutre SE, Damon LE, Erba HP, Estey E, Foran J, Lancet J, Maness LJ, Maslak PG, Millenson M, Moore JO, Przepiorka D, Shami P, Smith BD, Stone RM, Tallman … -
High-dose etoposide, thiotepa, and dose-adjusted carboplatin (TVCa) with autologous hematopoietic stem cell rescue as treatment of relapsed or refractory germ cell cancer.
American journal of clinical oncology 2005 Chaudhary UB, Damon LE, Rugo HS, Linker CA, Navarro W, Small EJ -
ACCO: ASCO core curriculum outline.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005 Muss HB, Von Roenn J, Damon LE, Deangelis LM, Flaherty LE, Harari PM, Kelly K, Kosty MP, Loscalzo MJ, Mennel R, Mitchell BS, Mortimer JE, Muggia F, Perez EA, Pisters PW, Saltz L, Schapira L, Sparano J… -
Baboon bone-marrow xenotransplant in a patient with advanced HIV disease: case report and 8-year follow-up.
Transplantation 2004 Michaels MG, Kaufman C, Volberding PA, Gupta P, Switzer WM, Heneine W, Sandstrom P, Kaplan L, Swift P, Damon L, Ildstad ST -
Thrombosis associated with L-asparaginase therapy and low fibrinogen levels in adult acute lymphoblastic leukemia.
American journal of hematology 2004 Beinart G, Damon L -
Prognostic indicators and survival in patients with stage IIIB inflammatory breast carcinoma after dose-intense chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004 Somlo G, Frankel P, Chow W, Leong L, Margolin K, Morgan R, Shibata S, Chu P, Forman S, Lim D, Twardowski P, Weitzel J, Alvarnas J, Kogut N, Schriber J, Fermin E, Yen Y, Damon L, Doroshow JH -
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule.
Cancer chemotherapy and pharmacology 2004 Damon LE, Johnston LJ, Ries CA, Rugo HS, Case D, Ault K, Linker CA -
Secondary acute leukemia following mitoxantrone-based high-dose chemotherapy for primary breast cancer patients.
Bone marrow transplantation 2003 Kröger N, Damon L, Zander AR, Wandt H, Derigs G, Ferrante P, Demirer T, Rosti G, Solid Tumor Working Party of the European Group for Blood and Marrow Transplantation, German Adjuvant Breast Cancer … -
High CD34+ cell dose promotes faster platelet recovery after autologous stem cell transplantation for acute myeloid leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2003 Gunn N, Damon L, Varosy P, Navarro W, Martin T, Ries C, Linker C -
Intensified and shortened cyclical chemotherapy for adult acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002 Linker C, Damon L, Ries C, Navarro W -
Autologous stem cell transplantation for advanced acute myeloid leukemia.
Bone marrow transplantation 2002 Linker CA, Damon LE, Ries CA, Navarro WA, Case D, Wolf JL -
The Trauma Symptom Checklist for Young Children (TSCYC): reliability and association with abuse exposure in a multi-site study.
Child abuse & neglect 2001 Briere J, Johnson K, Bissada A, Damon L, Crouch J, Gil E, Hanson R, Ernst V -
Child Sexual Behavior Inventory: normative, psychiatric, and sexual abuse comparisons.
Child maltreatment 2001 Friedrich WN, Fisher JL, Dittner CA, Acton R, Berliner L, Butler J, Damon L, Davies WH, Gray A, Wright J -
A case of factitious aplastic anemia.
International journal of psychiatry in medicine 2001 Bright R, Eisendrath S, Damon L -
High-dose chemotherapy (CTM) for breast cancer.
Bone marrow transplantation 2000 Damon LE, Wolf JL, Rugo HS, Gold E, Zander AR, Cassidy M, Cecchi G, Cohen N, Irwin D, Tracy M, Ries CA, Linker CA -
Autologous stem cell transplantation for acute myeloid leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000 Linker CA, Ries CA, Damon LE, Sayre P, Navarro W, Rugo HS, Rubin A, Case D, Crilley P, Topolsky D, Brodsky I, Zamkoff K, Wolfe JL -
High-dose chemotherapy and hematopoietic stem cell rescue for breast cancer: experience in California.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2000 Damon LE, Hu WW, Stockerl-Goldstein KE, Blume KG, Wolf JL, Gold E, Cecchi GR, Irwin D, Glaspy J, Territo I, Miller W, Mason JR, Linker CA -
Autologous bone marrow transplantation for acute myeloid leukemia using 4-hydroperoxycyclophosphamide-purged bone marrow and the busulfan/etoposide preparative regimen: a follow-up report.
Bone marrow transplantation 1998 Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL -
A randomized trial of high- vs standard-dose mitoxantrone with cytarabine in elderly patients with acute myeloid leukemia.
Leukemia 1997 Feldman EJ, Seiter K, Damon L, Linker C, Rugo H, Ries C, Case DC, Beer M, Ahmed T -
Successful immunomodulation with intravenous gamma globulin and cyclophosphamide in an alloimmunized heart transplant recipient.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1997 De Marco T, Damon LE, Colombe B, Keith F, Chatterjee K, Garovoy MR -
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997 Smith GA, Damon LE, Rugo HS, Ries CA, Linker CA -
The role of endoscopic evaluation in patients with suspected intestinal graft-versus-host disease after allogeneic bone-marrow transplantation.
Endoscopy 1996 Terdiman JP, Linker CA, Ries CA, Damon LE, Rugo HS, Ostroff JW -
High dose mitoxantrone with thiotepa, cyclophosphamide and autologous stem cell rescue for high risk stage II and stage III breast cancer. German GABG-4/EH-93-Study.
Bone marrow transplantation 1996 Zander AR, Krüger W, Kröger N, Damon L, Königmann M, Berdel WE, Gieseking F, Schäfer-Eckart K, Möbus V, Frickhofen N, Wandt H, Illiger HJ, Metzner B, Kolbe K, Wörmann B, Trümper L, Huber C, Hossfeld … -
Delayed engraftment of 4-hydroperoxycyclophosphamide-purged autologous bone marrow after induction treatment containing mitoxantrone for acute myelogenous leukemia.
Bone marrow transplantation 1996 Damon LE, Rugo HS, Ries CA, Linker CA -
Unreliability of the abdominal fat pad biopsy in the evaluation of nephrosis: report of 3 consecutive cases.
American journal of nephrology 1995 Lipschutz JH, Miller T, Yen TS, Vartanian RK, Graber ML, Damon L -
Post-remission cytopenias following intense induction chemotherapy for acute myeloid leukemia.
Leukemia 1994 Damon LE, Rugo HS, Ries CA, Linker CA -
High-dose chemotherapy for peripheral stem cell procurement in leukemia, lymphoma and multiple myeloma.
Progress in clinical and biological research 1994 Rugo HS, Damon LE, Ries CA, Wolf JL, Linker CA -
Busulfan plus etoposide as a preparative regimen for autologous bone marrow transplantation for acute myelogenous leukemia: an update.
Seminars in oncology 1993 Linker CA, Damon LE, Ries CA, Rugo HS, Wolf JL -
Gallium-avid thymic hyperplasia in an adult after chemotherapy for Hodgkin disease.
Cancer 1993 Small EJ, Venook AP, Damon LE -
Cyclosporine-induced hemolytic uremic syndrome in a heart transplant recipient.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993 Galli FC, Damon LE, Tomlanovich SJ, Keith F, Chatterjee K, DeMarco T -
Autologous bone marrow transplantation for acute myeloid leukemia using busulfan plus etoposide as a preparative regimen.
Blood 1993 Linker CA, Ries CA, Damon LE, Rugo HS, Wolf JL -
Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic.
Blood 1992 Thompson CE, Damon LE, Ries CA, Linker CA -
Anemias of chronic disease in the aged: diagnosis and treatment.
Geriatrics 1992 Damon LE -
Plasma and cerebrospinal fluid pharmacokinetics of 1-beta-D-arabinofuranosylcytosine and 1-beta-D-arabinofuranosyluracil following the repeated intravenous administration of high- and intermediate-dose 1-beta-D-arabinofuranosylcytosine.
Cancer research 1991 Damon LE, Plunkett W, Linker CA -
Sequence dependent synergistic cytotoxicity between etoposide and fluoropyrimidines.
Anticancer research 1989 Damon LE, Christensen S, Rochlitz C, Cadman EC -
The association between high-dose cytarabine neurotoxicity and renal insufficiency.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989 Damon LE, Mass R, Linker CA -
Enhancement of 5-fluorouracil antitumor effects by the prior administration of methotrexate.
Pharmacology & therapeutics 1989 Damon LE, Cadman E, Benz C -
Cytotoxicity of ketoconazole in malignant cell lines.
Cancer chemotherapy and pharmacology 1988 Rochlitz CF, Damon LE, Russi MB, Geddes A, Cadman EC -
The metabolic basis for combination chemotherapy.
Pharmacology & therapeutics 1988 Damon LE, Cadman EC -
Intracranial bleeding during treatment with hydroxyethyl starch.
The New England journal of medicine 1987 Damon L, Adams M, Stricker RB, Ries C -
Treatment issues with sexually abused young children.
Child welfare 1987 Damon L, Todd J, MacFarlane K -
A videotape parent education program for abusive parents.
Child abuse & neglect 1987 Golub JS, Espinosa M, Damon L, Card J -
Advances in rational combination chemotherapy.
Cancer investigation 1986 Damon LE, Cadman EC -
Effects of relocation on the elderly.
American family physician 1982 Damon LE